Description: SI-BONE is a medical device company that pioneered the iFuse Implant System, a minimally invasive surgical system for fusion of the sacroiliac joint to treat sacroiliac joint dysfunction. The SI joint is believed to be the last major joint with a clinically proven surgical treatment. The iFuse Implant, commercially available since 2009, is believed to be the only SI joint fusion device supported by multiple prospective clinical studies showing improved pain, patient function and quality of life resulting from treatment. There are over 60 peer-reviewed publications supporting the safety, effectiveness, and biomechanical and economic benefits unique to the iFuse Implant. This body of evidence has enabled multiple government and private payors to establish coverage of the SI joint fusion procedure exclusively when performed with the iFuse Implant System.
Home Page: si-bone.com
SIBN Technical Analysis
471 El Camino Real
Santa Clara,
CA
95050
United States
Phone:
408 207 0700
Officers
Name | Title |
---|---|
Ms. Laura A. Francis MBA | CEO & Director |
Mr. Anshul Maheshwari | Chief Financial Officer |
Mr. Anthony J. Recupero | Pres of Commercial Operations |
Mr. Michael A. Pisetsky | Sr. VP of Operations & Admin., Sec. and Chief Legal Officer |
Mr. Jeff Bertolini | Sr. VP of Operations & Information Technology |
Dr. Scott A. Yerby | Sr. VP of Engineering & CTO |
Mr. Joseph W. Powers | VP of Corp. Marketing |
Ms. Aimee Einstein | VP of People & Culture |
Dr. Daniel Joseph Cher | Sr. VP of Clinical & Regulatory Affairs |
Dr. W. Carlton Reckling | Chief Medical Officer & VP of Medical Affairs |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Supplies |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 4.2639 |
Price-to-Sales TTM: | 4.3152 |
IPO Date: | 2018-10-17 |
Fiscal Year End: | December |
Full Time Employees: | 352 |